[1] Brescó, M. S., Harris, L. G., Thompson, K., Stanic, B., Morgenstern, M., O’Mahony, L., Richards, R. G., & Moriarty, T. F. (2017). Pathogenic mechanisms and host interactions in Staphylococcus epidermidis device-related infection. Frontiers in Microbiology, 8(AUG). https://doi.org/10.3389/fmicb.2017.01401
[2]Vuong, C., & Otto, M. (2002). Staphylococcus epidermidis infections. Microbes and Infection, 4(4), 481–489. https://doi.org/10.1016/S1286-4579(02)01563-0. https://doi.org/10.1016/S1286-4579(02)01563-0.
[3]Yarawsky, A. E., Johns, S. L., Schuck, P., & Herr, A. B. (2020). The biofilm adhesion protein Aap from Staphylococcus epidermidis forms zinc-dependent amyloid fibers. Journal of Biological Chemistry, 295(14), 4411–4427. https://doi.org/10.1074/jbc.RA119.010874.
[4]Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018). Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence, 9(1), 522-554. https://doi.org/10.1080/21505594.2017.1313372.
[5]VanAken, S. M., Newton, D., & VanEpps, J. S. (2021). Improved diagnostic prediction of the pathogenicity of bloodstream isolates of Staphylococcus epidermidis. PLoS ONE, 16(3 March), 1–16. https://doi.org/10.1371/journal.pone.0241457.
[6]Kahkeshani, N., Farzaei, F., Fotouhi, M., Alavi, S. S., Bahramsoltani, R., Naseri, R., Momtaz, S., Abbasabadi, Z., Rahimi, R., & Farzaei, M. H. (2019). Pharmacological effects of gallic acid in health and diseases: A mechanistic review. Iranian Journal of Basic Medical Sciences, 22(3), 225. https://doi.org/10.22038%2Fijbms.2019.32806.7897.
[7]Lu, L., Hu, W., Tian, Z., Yuan, D., Yi, G., Zhou, Y., Cheng, Q., Zhu, J., & Li, M. (2019). Developing natural products as potential anti-biofilm agents. Chinese Medicine, 14(1), 1–17. https://doi.org/10.1186/s13020-019-0232-2. https://doi.org/10.3389/fmicb.2020.566325.
[8]Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016). Methods for in vitro evaluating antimicrobial activity: A review. Journal of pharmaceutical analysis, 6(2), 71-79. https://doi.org/10.1016/j.jpha.2015.11.005.
[9]Bertelloni, F., Cagnoli, G., & Ebani, V. V. (2021). Virulence and antimicrobial resistance in canine staphylococcus spp. Isolates. Microorganisms, 9(3), 515. https://doi.org/10.3390/microorganisms9030515.
[10]Sandasi, M., Leonard, C. M., & Viljoen, A. M. (2010). The in vitro antibiofilm activity of selected culinary herbs and medicinal plants against Listeria monocytogenes. Letters in applied microbiology, 50(1), 30-35. https://doi.org/10.1111/j.1472-765X.2009.02747.x.
[11]Djordjevic, D., Wiedmann, M., & McLandsborough, L. A. (2002). Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Applied and environmental microbiology, 68(6), 2950-2958. https://doi.org/10.1128/AEM.68.6.2950-2958.2002.
[12]Schillaci, D., Arizza, V., Dayton, T., Camarda, L., & Stefano, V. D. (2008). In vitro anti‐biofilm activity of Boswellia spp. oleogum resin essential oils. Letters in applied microbiology, 47(5), 433-438. https://doi.org/10.1111/j.1472-765X.2008.02469.x.
[13]Patel, S., Gheewala, N., Suthar, A., & Shah, A. (2009). In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line. Int J Pharm Pharm Sci, 1(1), 38-46.
[14]Liu, D., Zhu, Y., Chen, W., Li, M., Liu, S., & Zhang, Y. (2020). Multiple preoperative biomarkers are associated with incidence of surgical site infection following surgeries of ankle fractures. International Wound Journal, 17(3), 842-850. https://doi.org/10.1111/iwj.13351.
[15]Aragona, P., Baudouin, C., Del Castillo, J. M. B., Messmer, E., Barabino, S., Merayo-Lloves, J., ... & Labetoulle, M. (2021). The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. survey of ophthalmology, 66(6), 907-925. https://doi.org/10.1016/j.survophthal.2021.03.010.
[16]Chabi, R., & Momtaz, H. (2019). Virulence factors and antibiotic resistance properties of the Staphylococcus epidermidis strains isolated from hospital infections in Ahvaz, Iran. Tropical Medicine and Health, 47(1), 1–9. https://doi.org/10.1186/s41182-019-0180-7
[17]Behshood, P., Tajbakhsh, E., & Momtaz, H. (2020). Recognition of (Sesc) for Easy Identification of Staphylococcus Epidermidis and Molecular and Phenotypic Study of Β-Lactam Resistance in Staphylococcus Epidermidis Isolates in Isfahan. Reports of Biochemistry and Molecular Biology, 9(3), 309–314. https://doi.org/10.29252/RBMB.9.3.309.
[18]Chovanová, R., Mezovská, J., Vaverková, & Mikulášová, M. (2015). The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species. Letters in Applied Microbiology, 61(1), 58–62. https://doi.org/10.1111/lam.12424.
[19]He, H. J., Sun, F. J., Wang, Q., Liu, Y., Xiong, L. R., & Xia, P. Y. (2016). Erythromycin resistance features and biofilm formation affected by subinhibitory erythromycin in clinical isolates of Staphylococcus epidermidis. In Journal of Microbiology, Immunology and Infection (Vol. 49, Issue 1, pp. 33–40). https://doi.org/10.1016/j.jmii.2014.03.001
[20]Harris, L. G., Murray, S., Pascoe, B., Bray, J., Meric, G., Magerios, L., Wilkinson, T. S., Jeeves, R., Rohde, H., & Schwarz, S. (2016). Biofilm morphotypes and population structure among Staphylococcus epidermidis from commensal and clinical samples. PLoS One, 11(3), e0151240. https://doi.org/10.1371/journal.pone.0151240.
[21]Chi, H., & Holo, H. (2018). Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin B against gram-positive and gram-negative bacteria. Current Microbiology, 75, 272–277. doi.org/ 10.1007/s00284-017-1375-y.
[22]Montero, M., VanScoy, B. D., López-Causapé, C., Conde, H., Adams, J., Segura, C., Zamorano, L., Oliver, A., Horcajada, J. P., & Ambrose, P. G. (2018). Evaluation of ceftolozane-tazobactam in combination with meropenem against Pseudomonas aeruginosa sequence type 175 in a hollow-fiber infection model. Antimicrobial Agents and Chemotherapy, 62(5), 10–1128. https://doi.org/10.1128/aac.00026-18.
[23]Ayaz, M., Ullah, F., Sadiq, A., Ullah, F., Ovais, M., Ahmed, J., & Devkota, H. P. (2019). Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. Chemico-Biological Interactions, 308, 294–303. https://doi.org/10.1016/j.cbi.2019.05.050.
[24]Jadhav, S., Shah, R., Bhave, M., & Palombo, E. A. (2013). Inhibitory activity of yarrow essential oil on Listeria planktonic cells and biofilms. Food Control, 29(1), 125–130. https://doi.org/10.1016/j.foodcont.2012.05.071.
[25]de Oliveira, M. M. M., Brugnera, D. F., das Graças Cardoso, M., Alves, E., & Piccoli, R. H. (2010). Disinfectant action of Cymbopogon sp. essential oils in different phases of biofilm formation by Listeria monocytogenes on stainless steel surface. Food Control, 21(4), 549–553. https://doi.org/10.1016/j.foodcont.2009.08.003.
[26]Kouidhi, B., Zmantar, T., & Bakhrouf, A. (2010). Anti-cariogenic and anti-biofilms activity of Tunisian propolis extract and its potential protective effect against cancer cells proliferation. Anaerobe, 16(6), 566-571. https://doi.org/10.1016/j.anaerobe.2010.09.005.
[27]Mishra, R., Panda, A. K., De Mandal, S., Shakeel, M., Bisht, S. S., & Khan, J. (2020). Natural anti-biofilm agents: strategies to control biofilm-forming pathogens. Front Microbiol 11: 566325. https://doi.org/10.3389/fmicb.2020.566325.